All genes except ASB2 exhibited significantly increased tumor methylation as compared to normal prostate in all significant proximal probes, while ASB2 methylation was significantly decreased in TCGA prostate tumors at all significant probes within the promoter as well as its single proximal probe (Additional file 15: Figure S9, Table 5, Fig. 6). The gene discussed is ASB2; the disease is neoplasm.